【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 14
2 Introduction 15
2.1 Ovarian Cancer Overview 15
3 Products under Development 16
3.1 Ovarian Cancer – Pipeline Products by Stage of Development 16
3.2 Ovarian Cancer – Pipeline Products by Territory 17
3.3 Ovarian Cancer – Pipeline Products by Regulatory Path 18
3.4 Ovarian Cancer – Pipeline Products by Estimated Approval Date 19
3.5 Ovarian Cancer – Ongoing Clinical Trials 20
4 Ovarian Cancer – Pipeline Products under Development by Companies 21
4.1 Ovarian Cancer Companies – Pipeline Products by Stage of Development 21
4.2 Ovarian Cancer – Pipeline Products by Stage of Development 25
5 Ovarian Cancer Companies and Product Overview 29
5.1 A&G Pharmaceutical, Inc. Company Overview 29
5.1.1 A&G Pharmaceutical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
5.2 Abcodia Ltd. Company Overview 31
5.2.1 Abcodia Ltd. Pipeline Products & Ongoing Clinical Trials Overview 31
5.3 Abnova Corporation Company Overview 32
5.3.1 Abnova Corporation Pipeline Products & Ongoing Clinical Trials Overview 32
5.4 Adaptive Biotechnologies Corporation Company Overview 34
5.4.1 Adaptive Biotechnologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 34
5.5 Almac Diagnostics Limited Company Overview 35
5.5.1 Almac Diagnostics Limited Pipeline Products & Ongoing Clinical Trials Overview 35
5.6 AroCell AB Company Overview 36
5.6.1 AroCell AB Pipeline Products & Ongoing Clinical Trials Overview 36
5.7 Arrayit Diagnostics, Inc. Company Overview 37
5.7.1 Arrayit Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
5.8 ArtemixRx Company Overview 39
5.8.1 ArtemixRx Pipeline Products & Ongoing Clinical Trials Overview 39
5.9 Aurelium BioPharma Inc. (Inactive) Company Overview 40
5.9.1 Aurelium BioPharma Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 40
5.10 Axela Inc. Company Overview 42
5.10.1 Axela Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.11 Ayanda Biosystems S.A. Company Overview 43
5.11.1 Ayanda Biosystems S.A. Pipeline Products & Ongoing Clinical Trials Overview 43
5.12 Becton, Dickinson and Company Company Overview 44
5.12.1 Becton, Dickinson and Company Pipeline Products & Ongoing Clinical Trials Overview 44
5.13 Bioindustry Park Silvano Fumero S.p.A. Company Overview 46
5.13.1 Bioindustry Park Silvano Fumero S.p.A. Pipeline Products & Ongoing Clinical Trials Overview 46
5.14 BioMark Diagnostics Inc. Company Overview 47
5.14.1 BioMark Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
5.15 Ceres Nanosciences, Inc. Company Overview 48
5.15.1 Ceres Nanosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
5.16 Chronix Biomedical, Inc. Company Overview 50
5.16.1 Chronix Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
5.17 Clarient, Inc. Company Overview 52
5.17.1 Clarient, Inc. Pipeline Products & Ongoing Clinical Trials Overview 52
5.18 ClavGen Therapeutics LLC Company Overview 53
5.18.1 ClavGen Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 53
5.19 Cleveland Diagnostics Inc. Company Overview 54
5.19.1 Cleveland Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
5.20 Clovis Oncology, Inc. Company Overview 55
5.20.1 Clovis Oncology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
5.21 Cornell University Company Overview 57
5.21.1 Cornell University Pipeline Products & Ongoing Clinical Trials Overview 57
5.22 Courtagen Life Sciences, Inc. Company Overview 58
5.22.1 Courtagen Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 58
5.23 CS-Keys, Inc. Company Overview 59
5.23.1 CS-Keys, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
5.24 Dako A/S Company Overview 60
5.24.1 Dako A/S Pipeline Products & Ongoing Clinical Trials Overview 60
5.25 Dana-Farber Cancer Institute, Inc. Company Overview 61
5.25.1 Dana-Farber Cancer Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61
5.26 diaDexus, Inc. Company Overview 62
5.26.1 diaDexus, Inc. Pipeline Products & Ongoing Clinical Trials Overview 62
5.27 Eventus Diagnostics, Inc. Company Overview 67
5.27.1 Eventus Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
5.28 Exiqon A/S Company Overview 68
5.28.1 Exiqon A/S Pipeline Products & Ongoing Clinical Trials Overview 68
5.29 Exosomics Siena SpA Company Overview 70
5.29.1 Exosomics Siena SpA Pipeline Products & Ongoing Clinical Trials Overview 70
5.30 Foundation Medicine, Inc. Company Overview 71
5.30.1 Foundation Medicine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71
5.31 Ganymed Pharmaceuticals AG Company Overview 73
5.31.1 Ganymed Pharmaceuticals AG Pipeline Products & Ongoing Clinical Trials Overview 73
5.32 GeneNews Limited Company Overview 74
5.32.1 GeneNews Limited Pipeline Products & Ongoing Clinical Trials Overview 74
5.33 Georgia Institute of Technology Company Overview 76
5.33.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 76
5.34 GlycoZym Company Overview 78
5.34.1 GlycoZym Pipeline Products & Ongoing Clinical Trials Overview 78
5.35 H. Lee Moffitt Cancer Center & Research Institute, Inc. Company Overview 79
5.35.1 H. Lee Moffitt Cancer Center & Research Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 79
5.36 Ikonisys, Inc. Company Overview 80
5.36.1 Ikonisys, Inc. Pipeline Products & Ongoing Clinical Trials Overview 80
5.37 Inanovate (UK) Ltd. Company Overview 81
5.37.1 Inanovate (UK) Ltd. Pipeline Products & Ongoing Clinical Trials Overview 81
5.38 IncellDx, Inc. Company Overview 82
5.38.1 IncellDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 82
5.39 Innovative Health Diagnostics Company Overview 83
5.39.1 Innovative Health Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 83
5.40 Institut National de la Sante et de la Recherche Medicale Company Overview 84
5.40.1 Institut National de la Sante et de la Recherche Medicale Pipeline Products & Ongoing Clinical Trials Overview 84
5.41 InterGenetics Incorporated Company Overview 85
5.41.1 InterGenetics Incorporated Pipeline Products & Ongoing Clinical Trials Overview 85
5.42 IV Diagnostics, Inc. Company Overview 86
5.42.1 IV Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 86
5.43 KIYATEC Inc. Company Overview 87
5.43.1 KIYATEC Inc. Pipeline Products & Ongoing Clinical Trials Overview 87
5.44 Lab Discoveries Ltd. Company Overview 88
5.44.1 Lab Discoveries Ltd. Pipeline Products & Ongoing Clinical Trials Overview 88
5.45 Laboratorios SALVAT S.A. Company Overview 89
5.45.1 Laboratorios SALVAT S.A. Pipeline Products & Ongoing Clinical Trials Overview 89
5.46 Laboratory Corporation of America Holdings Company Overview 90
5.46.1 Laboratory Corporation of America Holdings Pipeline Products & Ongoing Clinical Trials Overview 90
5.47 Louisville Bioscience, Inc. Company Overview 92
5.47.1 Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 92
5.48 MabCure Inc. Company Overview 93
5.48.1 MabCure Inc. Pipeline Products & Ongoing Clinical Trials Overview 93
5.49 Manalto Limited Company Overview 95
5.49.1 Manalto Limited Pipeline Products & Ongoing Clinical Trials Overview 95
5.50 MDNA Life Sciences, Inc. Company Overview 100
5.50.1 MDNA Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 100
5.51 MDxHealth SA Company Overview 101
5.51.1 MDxHealth SA Pipeline Products & Ongoing Clinical Trials Overview 101
5.52 Metabolon, Inc. Company Overview 103
5.52.1 Metabolon, Inc. Pipeline Products & Ongoing Clinical Trials Overview 103
5.53 Milagen, Inc. Company Overview 104
5.53.1 Milagen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 104
5.54 Myriad Genetics, Inc. Company Overview 105
5.54.1 Myriad Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 105
5.55 Nanosphere, Inc. Company Overview 107
5.55.1 Nanosphere, Inc. Pipeline Products & Ongoing Clinical Trials Overview 107
5.56 National University of Singapore Company Overview 109
5.56.1 National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 109
5.57 Neogenix Oncology, Inc. Company Overview 110
5.57.1 Neogenix Oncology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 110
5.58 Novel Bio-spectrum Technologies, Inc. Company Overview 111
5.58.1 Novel Bio-spectrum Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 111
5.59 NuCana BioMed Limited Company Overview 112
5.59.1 NuCana BioMed Limited Pipeline Products & Ongoing Clinical Trials Overview 112
5.60 Oncgnostics GmbH Company Overview 113
5.60.1 Oncgnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 113
5.61 Orion Genomics LLC Company Overview 114
5.61.1 Orion Genomics LLC Pipeline Products & Ongoing Clinical Trials Overview 114
5.62 Oryzon Genomics S.A. Company Overview 115
5.62.1 Oryzon Genomics S.A. Pipeline Products & Ongoing Clinical Trials Overview 115
5.63 OTraces Inc. Company Overview 116
5.63.1 OTraces Inc. Pipeline Products & Ongoing Clinical Trials Overview 116
5.64 OvaGene Oncology Inc. Company Overview 117
5.64.1 OvaGene Oncology Inc. Pipeline Products & Ongoing Clinical Trials Overview 117
5.65 PeriRx LLC Company Overview 118
5.65.1 PeriRx LLC Pipeline Products & Ongoing Clinical Trials Overview 118
5.66 Pronota NV Company Overview 119
5.66.1 Pronota NV Pipeline Products & Ongoing Clinical Trials Overview 119
5.67 Protagen AG Company Overview 120
5.67.1 Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 120
5.68 Proteomika Company Overview 121
5.68.1 Proteomika Pipeline Products & Ongoing Clinical Trials Overview 121
5.69 Provista Diagnostics Inc. Company Overview 122
5.69.1 Provista Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 122
5.70 RCP Diagnostics, LLC (Inactive) Company Overview 123
5.70.1 RCP Diagnostics, LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 123
5.71 RiboMed Biotechnologies, Inc. Company Overview 124
5.71.1 RiboMed Biotechnologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 124
5.72 Rice University Company Overview 125
5.72.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 125
5.73 Roche Diagnostics International Ltd. Company Overview 127
5.73.1 Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview 127
5.74 Rosetta Genomics, Ltd. Company Overview 129
5.74.1 Rosetta Genomics, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 129
5.75 Rush University Medical Center Company Overview 131
5.75.1 Rush University Medical Center Pipeline Products & Ongoing Clinical Trials Overview 131
5.76 SomaLogic, Inc. Company Overview 132
5.76.1 SomaLogic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 132
5.77 Soricimed Biopharma Inc. Company Overview 133
5.77.1 Soricimed Biopharma Inc. Pipeline Products & Ongoing Clinical Trials Overview 133
5.78 Stage I Diagnostics, Inc. Company Overview 135
5.78.1 Stage I Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 135
5.79 SurExam Life Science & Technology Co. Company Overview 136
5.79.1 SurExam Life Science & Technology Co. Pipeline Products & Ongoing Clinical Trials Overview 136
5.80 Target Discovery, Inc. Company Overview 137
5.80.1 Target Discovery, Inc. Pipeline Products & Ongoing Clinical Trials Overview 137
5.81 Teva Pharmaceutical Industries Limited Company Overview 138
5.81.1 Teva Pharmaceutical Industries Limited Pipeline Products & Ongoing Clinical Trials Overview 138
5.82 The Johns Hopkins University Company Overview 140
5.82.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 140
5.83 The University of Adelaide Company Overview 142
5.83.1 The University of Adelaide Pipeline Products & Ongoing Clinical Trials Overview 142
5.84 The University of Texas M. D. Anderson Cancer Center Company Overview 143
5.84.1 The University of Texas M. D. Anderson Cancer Center Pipeline Products & Ongoing Clinical Trials Overview 143
5.85 Todos Medical Company Overview 144
5.85.1 Todos Medical Pipeline Products & Ongoing Clinical Trials Overview 144
5.86 Transbiomed, SL Company Overview 145
5.86.1 Transbiomed, SL Pipeline Products & Ongoing Clinical Trials Overview 145
5.87 Universite de Montreal Company Overview 146
5.87.1 Universite de Montreal Pipeline Products & Ongoing Clinical Trials Overview 146
5.88 University of South Florida Company Overview 148
5.88.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 148
5.89 US Biomarkers, Inc. Company Overview 150
5.89.1 US Biomarkers, Inc. Pipeline Products & Ongoing Clinical Trials Overview 150
5.90 Vermillion, Inc. Company Overview 151
5.90.1 Vermillion, Inc. Pipeline Products & Ongoing Clinical Trials Overview 151
5.91 Vitatex Inc. Company Overview 154
5.91.1 Vitatex Inc. Pipeline Products & Ongoing Clinical Trials Overview 154
5.92 Vitruvian Biomedical, Inc. Company Overview 157
5.92.1 Vitruvian Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 157
5.93 Yale University Company Overview 158
5.93.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview 158
6 Ovarian Cancer- Recent Developments 159
7 Appendix 171
7.1 Methodology 171
7.2 About GlobalData 173
7.3 Contact Us 174
7.4 Disclaimer 174
【レポート販売概要】
■ タイトル：世界における卵巣がん検査製品のパイプライン動向2015■ 英文：Ovarian Cancer - Pipeline Review, 2015
■ 発行日：2015年10月1日
■ 調査会社：GlobalData
■ 商品コード：GDME0074EPD
■ 調査対象地域：グローバル
- ホルモン補充療法(HRT)のグローバル市場（2014-2018）About Hormone Replacement Therapy Hormone replacement therapy, also known as hormone therapy, is a means of replacing hormones that are no longer being produced by the body. This type of therapy is usually initiated at menopause or may be started while a woman is in the perimenopausal phase, nearing menopause. Hormone replacement therapy replenishes the hormones required by the human body to funct …
- 世界のコロケーション料金情報サービス（年間購読）The Colocation Pricing Service provides in-depth pricing data and expert analysis for 32 major colocation markets around the world. All data are updated twice annually.
- Eladur（神経因性疼痛）：医薬品市場予測及び分析（～2022）Eladur (Neuropathic Pain) - Forecast and Market Analysis to 2022 Summary Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive pain, which is a consequence of trauma, injury, or inflammation. The main difference between neuropathic and nociceptive pain is the absence of a continuous nociceptive input in neuropathic pain. Although the …
- 世界の防爆形モータ/アクチュエータ市場2015The Global Explosion-proof Electric Motors and Actuators Industry Report 2015 is a professional and in-depth study on the current state of the Explosion-proof Electric Motors and Actuators industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Explosion-proof Electric Motors and Actuators market analysis …
- 医療用警告システム/個人用緊急対応システム（PERS）の世界市場The personal emergency response system market is expected to grow at a CAGR of 6.0% between 2015 and 2020. Constant innovation in the technology and easy adaptability of PERS devices are acting as the driver for the market. With the advancement of technology in the PERS market, auto fall detection technique or motion sensor pendent automatically detect when a senior citizen falls and cannot call f …
- 世界のプロテオミクス市場動向（2012-2016）TechNavio's analysts forecast the Global Proteomics market to grow at a CAGR of 14.43 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for personalized medicines. The Global Proteomics market has also been witnessing a shift from genomics to proteomics. However, the intense competition among vendors could pose a challenge to the …
- 米国の冬服市場2016-2020About Winter Wear in the US The market is highly seasonal and is driven by the climatic conditions of the region. With climate change having become a key issue the world over in the last few years and the increasingly warm winters in the country, vendors are likely to be unable to anticipate demand trends accurately. The warm winters experienced in late 2015, for instance, have had significant neg …
- 液体分配装置の世界市場分析：製品別（フラックス、潤滑剤、はんだペースト、接着剤およびシーラント（エポキシ接着剤、エポキシアンダーフィル）、絶縁保護コーティング）、用途別（電気・電子（半導体実装、プリント基板）、医療機器、自動車、建設）、セグメント予測The global fluid dispensing systems market is expected to reach USD 55.09 billion by 2024, according to a new report by Grand View Research, Inc. Growing electronic components manufacturing in Southeast Asia to drive growth. The trend towards miniaturization of electronic components and industry automation are key growth driving factors for the global fluid dispensing systems market. Recent innova …
- サイバーセキュリティ市場におけるM&A提携動向Mergers and acquisitions by cyber security providers are analyzed based on the impact of M&A on the cyber security market and the value of the deal. M&A’s tracked in cybersecurity market globally are divided into five major regions Asia Pacific (APAC), Europe, the Middle-East (MEA), and North America. Cyber security software is instrumental in providing authentication to the information exchange b …
- スポーツ保護具の世界市場2016-2020About Sports Protective Equipment Sports protective equipment includes gear for cycling, ball sports (baseball, soccer, football, softball, basketball, volleyball, cricket, hockey, racquet sports, and others), extreme sports (hard and soft adventure sports, motor racing, and paintball), and others (winter sports, archery, pogo sticks, billiards, martial arts, indoor games, in-line skating, bowling …
- Hyperparathyroidism：グローバル臨床試験レビューH2, 2013Hyperparathyroidism Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Hyperparathyroidism Global Clinical Trials Review, H2, 2013" provides data on the Hyperparathyroidism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyperparathyroidism. It includes an overview of the trial numbers and their recru …
- Cenovus Energy, Inc.：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Cenovus Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Cenovus Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source f …
- ポリヒドロキシアルカン酸（PHA）の世界市場予測（～2021）：種類別（単量体、共重合体、三元重合体）、製造技術別（細菌発酵、生合成、酵素触媒）、用途別（包装、バイオ医療、食品サービス、農業）“Increasing scope in end-user segments across the globe to drive the market for PHA.” The global market for Polyhydroxyalkanoate (PHA) is projected to grow from an estimated USD 73.6 million in 2016 to USD 93.5 million by 2021, at a CAGR of 4.88%. With the increasing focus on sustainability and favorable governmental green procurement policies, the market for biodegradable plastics such as PHA is …
- Portland General Electric Company：発電所及び企業SWTO分析2015Portland General Electric Company - Power Plants and SWOT Analysis, 2015 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - …
- 世界の電気外科手術装置市場：電気外科用発電機、電気外科手術用器具、アルゴン及び排煙管理システムAbout Electrosurgical Devices Electrosurgical devices are used in electrosurgery of tissues. The electrosurgical devices use high-frequency electric current to cut/remove, coagulate, and control bleeding. They are commonly used in many applications by the surgeons. During the process, heat is generated by the electrosurgical device, which is proportional to the resistance and diameter of the tissu …
